Certara (CERT) said Monday it has received a European Medicines Agency qualification for its Simcyp Simulator biosimulation software for use in regulatory submissions.
Simcyp Simulator is the only software qualified by the regulator for a physiologically-based pharmacokinetic modelling platform, the company said.